| （単位：千ドル） | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | - | - | - | - | - | - | - | 1,827 | 1,379 | 2,158 | - | 2,307 | 2,292 | - |
| 営業費用 | - | - | - | - | - | - | - | 2,241 | 1,747 | 2,502 | - | 2,661 | 2,729 | - |
| 営業利益 | - | - | - | - | - | - | - | -2,242 | -1,748 | -2,503 | - | -2,662 | -2,730 | - |
| 純利益 | -257 | -598 | -750 | -864 | -1,970 | -747 | -2,320 | -2,125 | -1,629 | -2,392 | -2,474 | -2,607 | -2,669 | -3,259 |
| 一株あたり利益 | - | - | - | - | - | - | - | -0.17 | -0.13 | -0.19 | - | -0.2 | -0.2 | - |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | -0.17 | -0.13 | -0.19 | - | -0.2 | -0.2 | - |